Lv4
444 积分 2021-12-03 加入
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
7小时前
待确认
Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
15小时前
已完结
Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer
1个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
2个月前
已完结
[Expression and significance of immune checkpoint B7-homolog 4 in endometrial cancer]
2个月前
已完结
Diagnosis value of serum B7-H3 expression in non-small cell lung cancer
2个月前
已完结
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients
2个月前
已完结
The global burden of disease attributable to high body mass index in 204 countries and territories: Findings from 1990 to 2019 and predictions to 2035
4个月前
已完结
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
4个月前
已完结
Preclinical Characterization of AZD9574, a Blood–Brain Barrier Penetrant Inhibitor of PARP1
4个月前
已完结
皖公网安备34019202002308
